Works matching DE "MESOTHELIN"


Results: 99
    1
    2
    3
    4
    5

    C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.

    Published in:
    Journal of Gastroenterology, 2014, v. 49, n. 1, p. 81, doi. 10.1007/s00535-013-0773-6
    By:
    • Kawamata, Futoshi;
    • Homma, Shigenori;
    • Kamachi, Hirofumi;
    • Einama, Takahiro;
    • Kato, Yasutaka;
    • Tsuda, Masumi;
    • Tanaka, Shinya;
    • Maeda, Masahiro;
    • Kajino, Kazunori;
    • Hino, Okio;
    • Takahashi, Norihiko;
    • Kamiyama, Toshiya;
    • Nishihara, Hiroshi;
    • Taketomi, Akinobu;
    • Todo, Satoru
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Eradicating mesothelin-positive human gastric and pancreatic tumors in xenograft models with optimized anti-mesothelin antibody–drug conjugates from synthetic antibody libraries.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94902-1
    By:
    • Hsu, Hung-Ju;
    • Tung, Chao-Ping;
    • Yu, Chung-Ming;
    • Chen, Chi-Yung;
    • Chen, Hong-Sen;
    • Huang, Yu-Chuan;
    • Tsai, Pei-Hsun;
    • Lin, Su-I;
    • Peng, Hung-Pin;
    • Chiu, Yi-Kai;
    • Tsou, Yueh-Liang;
    • Kuo, Wei-Ying;
    • Jian, Jhih-Wei;
    • Hung, Fei-Hung;
    • Hsieh, Chiao-Yun;
    • Hsiao, Michael;
    • Chuang, Simon Shih-Hsien;
    • Shen, Chia-Ning;
    • Wang, Yong Alison;
    • Yang, An-Suei
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Inhibition of Mesothelin as a Novel Strategy for Targeting Cancer Cells.

    Published in:
    PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0033214
    By:
    • Kun Wang;
    • Bodempudi, Vidya;
    • Zhengian Liu;
    • Borrego-Diaz, Emma;
    • Yamoutpoor, Farnaz;
    • Meyer, Anna;
    • Woo, Richard A.;
    • Weihong Pan;
    • Dudek, Arkadiusz Z.;
    • Olyaee, Mojtaba S.;
    • Esfandyari, Tuba;
    • Farassati, Faris
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.

    Published in:
    PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186137
    By:
    • Alfaleh, Mohamed A.;
    • Howard, Christopher B.;
    • Sedliarou, Ilya;
    • Jones, Martina L.;
    • Gudhka, Reema;
    • Vanegas, Natasha;
    • Weiss, Jocelyn;
    • Suurbach, Julia H.;
    • de Bakker, Christopher J.;
    • Milne, Michael R.;
    • Rumballe, Bree A.;
    • MacDiarmid, Jennifer A.;
    • Brahmbhatt, Himanshu;
    • Mahler, Stephen M.
    Publication type:
    Article
    42
    43
    44

    Mesothelin Expression in Pancreatic Mucinous Cysts.

    Published in:
    American Journal of Clinical Pathology, 2014, v. 142, n. 3, p. 313, doi. 10.1309/AJCPDTTL2I5ECMFG
    By:
    • Frank, Renee;
    • Shaoying Li;
    • Ahmad, Nuzhat A.;
    • Sepulveda, Antonia R.;
    • Jhala, Nirag C.
    Publication type:
    Article
    45

    Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.

    Published in:
    Journal of Neuro-Oncology, 2016, v. 130, n. 3, p. 543, doi. 10.1007/s11060-016-2256-0
    By:
    • Han, Seunggu;
    • Reis, Gerald;
    • Kohanbash, Gary;
    • Shrivastav, Shruti;
    • Magill, Stephen;
    • Molinaro, Annette;
    • McDermott, Michael;
    • Theodosopoulos, Philip;
    • Aghi, Manish;
    • Berger, Mitchel;
    • Butowski, Nicholas;
    • Barani, Igor;
    • Phillips, Joanna;
    • Perry, Arie;
    • Okada, Hideho
    Publication type:
    Article
    46
    47
    48
    49
    50